# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Johnny Cash (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML004-SYN-TD
- Date: 2003-02-27
- Fictional facility: St. Posthumous Health Center
- Fictional author: Gideon Hale, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Reason for visit

Primary care new-patient visit for diabetes, lightheadedness on standing, and glaucoma follow-up. **S**

## Historical basis

- J. R. (Johnny) Cash was born on February 26, 1932, in Kingsland, Cleveland County, Arkansas, to Ray and Carrie Cash. **D**
- Cash's older brother Jack died in a sawmill accident in 1944. **D**
- In 1957 Cash began taking amphetamines to stay awake on a long road trip, the start of an addiction that lasted about a decade; in a 2002 interview he named amphetamines and barbiturates in the 1960s. **D**
- Cash was hospitalized in 1983 with internal bleeding; after recovering he entered the Betty Ford Clinic for treatment. **D**
- In October 1997 Cash was diagnosed with Shy-Drager syndrome, an illness similar to Parkinson's disease; in a 2000 interview he said the diagnosis was a misdiagnosis. **D**
- Cash later learned he had autonomic neuropathy; in November 2002 he described it as a deadening of the nerve endings in his lower extremities that had taken the strength from his legs, so that he could walk, but not very well. **D**
- Cash was repeatedly hospitalized for pneumonia in his last years; he was treated for pneumonia at Baptist Hospital in Nashville in February 2001, and in November 2002 he said he had had pneumonia four times in three years. **D**
- In November 2002 Cash said about 60 percent of his vision was gone, which he attributed to the neuropathy and the diabetes, and he said he hoped the glaucoma could also be reversed. **D**

1 later historical claim is omitted because it describes events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- Lightheaded when he stands and afraid of another fall; was once told he had Shy-Drager syndrome and wants to know what he really has. **S**
- Wants to keep the sight he has left so he can keep writing songs. **S**

## Strengths and supports

- Supports: a family member who comes to visits and fills his pill organizer, and his church community **S**

## Medications and allergies

- Metformin 500 mg oral tablet, one tablet by mouth twice daily with meals **S**
- Metformin 1000 mg oral tablet, one tablet by mouth twice daily with meals **S**
- Atorvastatin 40 mg oral tablet, one tablet by mouth daily **S**
- Latanoprost 0.005% ophthalmic solution, one drop in each eye at bedtime **S**
- Dorzolamide 2% ophthalmic solution, one drop in each eye twice daily **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- 1957: Amphetamine use beginning in 1957, with barbiturates in the 1960s; addiction lasting about a decade **D** (CLM-0004)
- 1983: Hospitalized in 1983 with internal bleeding, followed by treatment at the Betty Ford Clinic **D** (CLM-0005)
- October 1997: Diagnosed with Shy-Drager syndrome in October 1997; he said in 2000 that it was a misdiagnosis, and autonomic neuropathy was later identified **D** (CLM-0006, CLM-0007)
- February 2001: Pneumonia treated at Baptist Hospital in Nashville in February 2001, one of several pneumonia admissions **D** (CLM-0008)

## Procedures and immunizations

- 2003-02-27 to 2003-02-27: Comprehensive diabetic foot examination with 10-g monofilament and vibration testing **S**
- 2003-02-27 to 2003-02-27: Optical coherence tomography of the optic nerve and retinal nerve fiber layer, both eyes **S**
- 2003-02-27 to 2003-02-27: Dilated eye examination and Humphrey 24-2 visual field testing, both eyes **S**
- 2002-10-20: High-dose influenza vaccine, 2002-2003 season **S**
- 2003-02-27: Pneumococcal conjugate vaccine PCV20 **S**

## Family history

- brother: Older brother Jack died in a sawmill accident in 1944 **D** (CLM-0003)

## Measurements

HbA1c: 8.6% (high); Sodium: 138 mmol/L; Potassium: 4.4 mmol/L; Creatinine: 1.04 mg/dL; eGFR: 74 mL/min/1.73 m²; Glucose: 186 mg/dL (high); LDL cholesterol: 128 mg/dL (high); Urine albumin-creatinine ratio: 18 mg/g; ALT: 24 U/L; AST: 22 U/L; Vitamin B12: 286 pg/mL; TSH: 1.9 mIU/L; Hemoglobin: 13.8 g/dL; Intraocular pressure, right eye: 22 mmHg (high); Intraocular pressure, left eye: 24 mmHg (high); Mean RNFL thickness by OCT, right eye: 61 um (low); Mean RNFL thickness by OCT, left eye: 57 um (low); Best-corrected visual acuity, right eye (ETDRS letters): 68 (low); Best-corrected visual acuity, left eye (ETDRS letters): 63 (low); PHQ-2: 1; Mini-Cog: 5. All results are synthetic.

BP 146/80 mmHg; pulse 78 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 95% on room air; weight 96 kg; BMI 27.2 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, oriented, and wry; speaks frankly about his past substance use and his faith; Mood euthymic; PHQ-2 negative; Mini-Cog normal. Functional status: Orthostatic vital signs at intake: 146/80 seated and 112/68 after three minutes standing, heart rate 78 to 82; lightheaded on standing and two falls in six months; Walks with a cane; reduced vibration and monofilament sensation to the ankles in both feet; independent in basic activities of daily living; Low vision from advanced glaucoma: tunnel vision in both eyes and difficulty in dim light; no longer drives. Physical examination is intentionally limited. **S**

## Assessment

1. Type 2 diabetes mellitus with diabetic autonomic neuropathy; HbA1c above the individualized goal at intake; status draft. **S**
2. Neurogenic orthostatic hypotension from diabetic autonomic neuropathy; status draft. **S**
3. Diabetic distal symmetric polyneuropathy with loss of protective sensation in both feet; status draft. **S**
4. Primary open-angle glaucoma, both eyes, severe stage; status draft. **S**
5. Mild nonproliferative diabetic retinopathy without macular edema, both eyes; status draft. **S**
6. Hyperlipidemia; status draft. **S**
7. History of recurrent pneumonia; status draft. **S**

## Plan

- Increase metformin to 1000 mg twice daily and set an individualized HbA1c goal below 7.5%; avoid insulin and sulfonylureas while autonomic neuropathy may blunt warning symptoms of hypoglycemia. Guideline: Standards of Care in Diabetes—2025 (2025); CMID: Clinical Monitoring Intelligence Database, diabetes, glaucoma, and hyperlipidemia monographs (2026) **S**
- Endocrinology consultation to confirm diabetic autonomic neuropathy as the cause of orthostatic hypotension, reconsider the earlier Shy-Drager label, and choose add-on glucose-lowering therapy. Guideline: Standards of Care in Diabetes—2025 (2025) **S**
- Treat neurogenic orthostatic hypotension: stand up in stages, raise the head of the bed, use waist-high compression, drink 2 liters of fluid a day, then midodrine with the last dose at least four hours before bed; check supine blood pressure at each visit. Guideline: Standards of Care in Diabetes—2025 (2025) **S**
- Check HbA1c every three months until at goal, a basic metabolic panel, UACR, and lipids each year, lipids 4 to 12 weeks after starting a statin, and vitamin B12 periodically on metformin. Guideline: Standards of Care in Diabetes—2025 (2025); CMID: Clinical Monitoring Intelligence Database, diabetes, glaucoma, and hyperlipidemia monographs (2026) **S**
- Examine the feet at every visit because of sensory loss; daily self-inspection and protective footwear. Guideline: Standards of Care in Diabetes—2025 (2025); CMID: Clinical Monitoring Intelligence Database, diabetes, glaucoma, and hyperlipidemia monographs (2026) **S**
- Coordinate glaucoma care with the eye clinic: add dorzolamide to latanoprost, check pressure at each visit, and repeat OCT and visual fields every six months; avoid timolol and brimonidine because of bradycardia, bronchospasm, and low blood pressure. Guideline: Primary Open-Angle Glaucoma Preferred Practice Pattern (2025); CMID: Clinical Monitoring Intelligence Database, diabetes, glaucoma, and hyperlipidemia monographs (2026) **S**
- Annual dilated eye examination for diabetic retinopathy; low-vision rehabilitation and home lighting review. Guideline: Standards of Care in Diabetes—2025 (2025); Primary Open-Angle Glaucoma Preferred Practice Pattern (2025) **S**
- Start atorvastatin 40 mg; give PCV20 and recombinant zoster vaccines. Guideline: Standards of Care in Diabetes—2025 (2025) **S**

## Guideline basis

- Standards of Care in Diabetes—2025 (2025), American Diabetes Association
- Primary Open-Angle Glaucoma Preferred Practice Pattern (2025), American Academy of Ophthalmology
- CMID: Clinical Monitoring Intelligence Database, diabetes, glaucoma, and hyperlipidemia monographs (2026), Aether Forge
